Physician profile
Ralph Gregg
NPI 1790775286
$619.33
in general payments reported to CMS, 2019-2025
11 companies · $201 in 2025
The $201 reported for 2025 was more than what 81% of Anesthesiology providers received nationally (typical 2025 total: $58.09).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $208 · 2021: $94.16 · 2022: $60.83 · 2023: $39.28 · 2024: $15.68 · 2025: $201.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $256.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $255.86 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abiomed | $201.72 | 2019-2025 | |
| La Jolla Pharmaceutical Company | $120.65 | 2019 | |
| Merck Sharp & Dohme LLC | $69.85 | 2021-2024 | Bridion |
| Edwards Lifesciences Corporation | $41.60 | 2019-2021 | |
| Masimo Corporation | $38.73 | 2021-2022 | |
| Becton, Dickinson and Company | $35.90 | 2025 | Hemosphere |
| Pacira Pharmaceuticals Incorporated | $33.92 | 2019-2023 | Exparel |
| Haemonetics Corporation | $25.67 | 2021 | |
| Eagle Pharmaceuticals, INC. | $20.33 | 2023 | |
| Avanos Medical | $17.03 | 2021 | |
| Medtronic Vascular, INC. | $13.93 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ralph Gregg listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.